Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Based Molecular Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Instruments
1.2.3 Reagents
1.3 Market by Application
1.3.1 Global Oncology Based Molecular Diagnostic Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Cervical Cancer
1.3.6 Liver Cancer
1.3.7 Lung Cancer
1.3.8 Blood Cancer
1.3.9 Kidney Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Based Molecular Diagnostic Market Perspective (2018-2033)
2.2 Oncology Based Molecular Diagnostic Growth Trends by Region
2.2.1 Global Oncology Based Molecular Diagnostic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Oncology Based Molecular Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 Oncology Based Molecular Diagnostic Forecasted Market Size by Region (2024-2033)
2.3 Oncology Based Molecular Diagnostic Market Dynamics
2.3.1 Oncology Based Molecular Diagnostic Industry Trends
2.3.2 Oncology Based Molecular Diagnostic Market Drivers
2.3.3 Oncology Based Molecular Diagnostic Market Challenges
2.3.4 Oncology Based Molecular Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Based Molecular Diagnostic Players by Revenue
3.1.1 Global Top Oncology Based Molecular Diagnostic Players by Revenue (2018-2023)
3.1.2 Global Oncology Based Molecular Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Based Molecular Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Based Molecular Diagnostic Revenue
3.4 Global Oncology Based Molecular Diagnostic Market Concentration Ratio
3.4.1 Global Oncology Based Molecular Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Based Molecular Diagnostic Revenue in 2022
3.5 Oncology Based Molecular Diagnostic Key Players Head office and Area Served
3.6 Key Players Oncology Based Molecular Diagnostic Product Solution and Service
3.7 Date of Enter into Oncology Based Molecular Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Based Molecular Diagnostic Breakdown Data by Type
4.1 Global Oncology Based Molecular Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Type (2024-2033)
5 Oncology Based Molecular Diagnostic Breakdown Data by Application
5.1 Global Oncology Based Molecular Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Oncology Based Molecular Diagnostic Market Size (2018-2033)
6.2 North America Oncology Based Molecular Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Oncology Based Molecular Diagnostic Market Size by Country (2018-2023)
6.4 North America Oncology Based Molecular Diagnostic Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Based Molecular Diagnostic Market Size (2018-2033)
7.2 Europe Oncology Based Molecular Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Oncology Based Molecular Diagnostic Market Size by Country (2018-2023)
7.4 Europe Oncology Based Molecular Diagnostic Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Based Molecular Diagnostic Market Size (2018-2033)
8.2 Asia-Pacific Oncology Based Molecular Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2018-2023)
8.4 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Based Molecular Diagnostic Market Size (2018-2033)
9.2 Latin America Oncology Based Molecular Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Oncology Based Molecular Diagnostic Market Size by Country (2018-2023)
9.4 Latin America Oncology Based Molecular Diagnostic Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Based Molecular Diagnostic Market Size (2018-2033)
10.2 Middle East & Africa Oncology Based Molecular Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2018-2023)
10.4 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Oncology Based Molecular Diagnostic Introduction
11.1.4 Abbott Revenue in Oncology Based Molecular Diagnostic Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Company Detail
11.2.2 Bayer Healthcare Business Overview
11.2.3 Bayer Healthcare Oncology Based Molecular Diagnostic Introduction
11.2.4 Bayer Healthcare Revenue in Oncology Based Molecular Diagnostic Business (2018-2023)
11.2.5 Bayer Healthcare Recent Development
11.3 Beckton Dickinson
11.3.1 Beckton Dickinson Company Detail
11.3.2 Beckton Dickinson Business Overview
11.3.3 Beckton Dickinson Oncology Based Molecular Diagnostic Introduction
11.3.4 Beckton Dickinson Revenue in Oncology Based Molecular Diagnostic Business (2018-2023)
11.3.5 Beckton Dickinson Recent Development
11.4 Cepheid
11.4.1 Cepheid Company Detail
11.4.2 Cepheid Business Overview
11.4.3 Cepheid Oncology Based Molecular Diagnostic Introduction
11.4.4 Cepheid Revenue in Oncology Based Molecular Diagnostic Business (2018-2023)
11.4.5 Cepheid Recent Development
11.5 Dako
11.5.1 Dako Company Detail
11.5.2 Dako Business Overview
11.5.3 Dako Oncology Based Molecular Diagnostic Introduction
11.5.4 Dako Revenue in Oncology Based Molecular Diagnostic Business (2018-2023)
11.5.5 Dako Recent Development
11.6 Hologic
11.6.1 Hologic Company Detail
11.6.2 Hologic Business Overview
11.6.3 Hologic Oncology Based Molecular Diagnostic Introduction
11.6.4 Hologic Revenue in Oncology Based Molecular Diagnostic Business (2018-2023)
11.6.5 Hologic Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Oncology Based Molecular Diagnostic Introduction
11.7.4 Qiagen Revenue in Oncology Based Molecular Diagnostic Business (2018-2023)
11.7.5 Qiagen Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Oncology Based Molecular Diagnostic Introduction
11.8.4 Roche Revenue in Oncology Based Molecular Diagnostic Business (2018-2023)
11.8.5 Roche Recent Development
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Detail
11.9.2 Siemens Healthineers Business Overview
11.9.3 Siemens Healthineers Oncology Based Molecular Diagnostic Introduction
11.9.4 Siemens Healthineers Revenue in Oncology Based Molecular Diagnostic Business (2018-2023)
11.9.5 Siemens Healthineers Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Detail
11.10.2 Sysmex Business Overview
11.10.3 Sysmex Oncology Based Molecular Diagnostic Introduction
11.10.4 Sysmex Revenue in Oncology Based Molecular Diagnostic Business (2018-2023)
11.10.5 Sysmex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oncology Based Molecular Diagnostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Instruments
Table 3. Key Players of Reagents
Table 4. Global Oncology Based Molecular Diagnostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Oncology Based Molecular Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Oncology Based Molecular Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Oncology Based Molecular Diagnostic Market Share by Region (2018-2023)
Table 8. Global Oncology Based Molecular Diagnostic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Oncology Based Molecular Diagnostic Market Share by Region (2024-2033)
Table 10. Oncology Based Molecular Diagnostic Market Trends
Table 11. Oncology Based Molecular Diagnostic Market Drivers
Table 12. Oncology Based Molecular Diagnostic Market Challenges
Table 13. Oncology Based Molecular Diagnostic Market Restraints
Table 14. Global Oncology Based Molecular Diagnostic Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Oncology Based Molecular Diagnostic Market Share by Players (2018-2023)
Table 16. Global Top Oncology Based Molecular Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Molecular Diagnostic as of 2022)
Table 17. Ranking of Global Top Oncology Based Molecular Diagnostic Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Oncology Based Molecular Diagnostic Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oncology Based Molecular Diagnostic Product Solution and Service
Table 21. Date of Enter into Oncology Based Molecular Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oncology Based Molecular Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Oncology Based Molecular Diagnostic Revenue Market Share by Type (2018-2023)
Table 25. Global Oncology Based Molecular Diagnostic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Oncology Based Molecular Diagnostic Revenue Market Share by Type (2024-2033)
Table 27. Global Oncology Based Molecular Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Oncology Based Molecular Diagnostic Revenue Market Share by Application (2018-2023)
Table 29. Global Oncology Based Molecular Diagnostic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Oncology Based Molecular Diagnostic Revenue Market Share by Application (2024-2033)
Table 31. North America Oncology Based Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Oncology Based Molecular Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Oncology Based Molecular Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Oncology Based Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Oncology Based Molecular Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Oncology Based Molecular Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Oncology Based Molecular Diagnostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Oncology Based Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Oncology Based Molecular Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Oncology Based Molecular Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Oncology Based Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 46. Abbott Company Detail
Table 47. Abbott Business Overview
Table 48. Abbott Oncology Based Molecular Diagnostic Product
Table 49. Abbott Revenue in Oncology Based Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. Bayer Healthcare Company Detail
Table 52. Bayer Healthcare Business Overview
Table 53. Bayer Healthcare Oncology Based Molecular Diagnostic Product
Table 54. Bayer Healthcare Revenue in Oncology Based Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 55. Bayer Healthcare Recent Development
Table 56. Beckton Dickinson Company Detail
Table 57. Beckton Dickinson Business Overview
Table 58. Beckton Dickinson Oncology Based Molecular Diagnostic Product
Table 59. Beckton Dickinson Revenue in Oncology Based Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 60. Beckton Dickinson Recent Development
Table 61. Cepheid Company Detail
Table 62. Cepheid Business Overview
Table 63. Cepheid Oncology Based Molecular Diagnostic Product
Table 64. Cepheid Revenue in Oncology Based Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 65. Cepheid Recent Development
Table 66. Dako Company Detail
Table 67. Dako Business Overview
Table 68. Dako Oncology Based Molecular Diagnostic Product
Table 69. Dako Revenue in Oncology Based Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 70. Dako Recent Development
Table 71. Hologic Company Detail
Table 72. Hologic Business Overview
Table 73. Hologic Oncology Based Molecular Diagnostic Product
Table 74. Hologic Revenue in Oncology Based Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 75. Hologic Recent Development
Table 76. Qiagen Company Detail
Table 77. Qiagen Business Overview
Table 78. Qiagen Oncology Based Molecular Diagnostic Product
Table 79. Qiagen Revenue in Oncology Based Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 80. Qiagen Recent Development
Table 81. Roche Company Detail
Table 82. Roche Business Overview
Table 83. Roche Oncology Based Molecular Diagnostic Product
Table 84. Roche Revenue in Oncology Based Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 85. Roche Recent Development
Table 86. Siemens Healthineers Company Detail
Table 87. Siemens Healthineers Business Overview
Table 88. Siemens Healthineers Oncology Based Molecular Diagnostic Product
Table 89. Siemens Healthineers Revenue in Oncology Based Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 90. Siemens Healthineers Recent Development
Table 91. Sysmex Company Detail
Table 92. Sysmex Business Overview
Table 93. Sysmex Oncology Based Molecular Diagnostic Product
Table 94. Sysmex Revenue in Oncology Based Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 95. Sysmex Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Based Molecular Diagnostic Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Oncology Based Molecular Diagnostic Market Share by Type: 2022 VS 2033
Figure 3. Instruments Features
Figure 4. Reagents Features
Figure 5. Global Oncology Based Molecular Diagnostic Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Oncology Based Molecular Diagnostic Market Share by Application: 2022 VS 2033
Figure 7. Breast Cancer Case Studies
Figure 8. Prostate Cancer Case Studies
Figure 9. Colorectal Cancer Case Studies
Figure 10. Cervical Cancer Case Studies
Figure 11. Liver Cancer Case Studies
Figure 12. Lung Cancer Case Studies
Figure 13. Blood Cancer Case Studies
Figure 14. Kidney Cancer Case Studies
Figure 15. Oncology Based Molecular Diagnostic Report Years Considered
Figure 16. Global Oncology Based Molecular Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Oncology Based Molecular Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Oncology Based Molecular Diagnostic Market Share by Region: 2022 VS 2033
Figure 19. Global Oncology Based Molecular Diagnostic Market Share by Players in 2022
Figure 20. Global Top Oncology Based Molecular Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Molecular Diagnostic as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Oncology Based Molecular Diagnostic Revenue in 2022
Figure 22. North America Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Oncology Based Molecular Diagnostic Market Share by Country (2018-2033)
Figure 24. United States Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Oncology Based Molecular Diagnostic Market Share by Country (2018-2033)
Figure 28. Germany Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Oncology Based Molecular Diagnostic Market Share by Region (2018-2033)
Figure 36. China Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Oncology Based Molecular Diagnostic Market Share by Country (2018-2033)
Figure 44. Mexico Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Oncology Based Molecular Diagnostic Market Share by Country (2018-2033)
Figure 48. Turkey Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Oncology Based Molecular Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Abbott Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2018-2023)
Figure 51. Bayer Healthcare Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2018-2023)
Figure 52. Beckton Dickinson Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2018-2023)
Figure 53. Cepheid Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2018-2023)
Figure 54. Dako Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2018-2023)
Figure 55. Hologic Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2018-2023)
Figure 56. Qiagen Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2018-2023)
Figure 57. Roche Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2018-2023)
Figure 58. Siemens Healthineers Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2018-2023)
Figure 59. Sysmex Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed